
Aradhana Sasan
Examiner (ID: 9005, Phone: (571)272-9022 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 1310 |
| Issued Applications | 752 |
| Pending Applications | 117 |
| Abandoned Applications | 467 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10353361
[patent_doc_number] => 20150238366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'Hemostatic Bioabsorbable Device with Polyethylene Glycol Binder'
[patent_app_type] => utility
[patent_app_number] => 14/707559
[patent_app_country] => US
[patent_app_date] => 2015-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5680
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14707559
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/707559 | Hemostatic bioabsorbable device with polyethylene glycol binder | May 7, 2015 | Issued |
Array
(
[id] => 10566242
[patent_doc_number] => 09289391
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-22
[patent_title] => 'Controlled release hydrocodone formulations'
[patent_app_type] => utility
[patent_app_number] => 14/706699
[patent_app_country] => US
[patent_app_date] => 2015-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12988
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14706699
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/706699 | Controlled release hydrocodone formulations | May 6, 2015 | Issued |
Array
(
[id] => 14516291
[patent_doc_number] => 10335379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Oral dosage forms of ketamine
[patent_app_type] => utility
[patent_app_number] => 15/304613
[patent_app_country] => US
[patent_app_date] => 2015-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 9103
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 317
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15304613
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/304613 | Oral dosage forms of ketamine | Apr 15, 2015 | Issued |
Array
(
[id] => 10379919
[patent_doc_number] => 20150264926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'Corrosive Ingredient(s)-Containing Compositions Having Reduced Toxicity And Method Of Obtaining'
[patent_app_type] => utility
[patent_app_number] => 14/666562
[patent_app_country] => US
[patent_app_date] => 2015-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6180
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14666562
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/666562 | Corrosive ingredient(s)-containing compositions having reduced toxicity and method of obtaining | Mar 23, 2015 | Issued |
Array
(
[id] => 10380733
[patent_doc_number] => 20150265741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'WOUND MANAGEMENT SYSTEM AND METHODS OF USING'
[patent_app_type] => utility
[patent_app_number] => 14/664264
[patent_app_country] => US
[patent_app_date] => 2015-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4354
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14664264
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/664264 | Wound management system and methods of using | Mar 19, 2015 | Issued |
Array
(
[id] => 10705435
[patent_doc_number] => 20160051582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CHRONIC PAIN'
[patent_app_type] => utility
[patent_app_number] => 14/659608
[patent_app_country] => US
[patent_app_date] => 2015-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3531
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14659608
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/659608 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CHRONIC PAIN | Mar 15, 2015 | Abandoned |
Array
(
[id] => 10774610
[patent_doc_number] => 20160120766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'COLLOIDAL FACIAL MASK WITH PARTIAL CARRIER AND METHOD FOR MANUFACTURING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/656325
[patent_app_country] => US
[patent_app_date] => 2015-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5474
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14656325
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/656325 | Colloidal facial mask with partial carrier and method for manufacturing the same | Mar 11, 2015 | Issued |
Array
(
[id] => 10634583
[patent_doc_number] => 09352070
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-31
[patent_title] => 'Tissue prostheses for repairing, reconstructing and replacing damaged or diseased biological structures and associated tissue'
[patent_app_type] => utility
[patent_app_number] => 14/635118
[patent_app_country] => US
[patent_app_date] => 2015-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 8
[patent_no_of_words] => 8131
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14635118
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/635118 | Tissue prostheses for repairing, reconstructing and replacing damaged or diseased biological structures and associated tissue | Mar 1, 2015 | Issued |
Array
(
[id] => 10279850
[patent_doc_number] => 20150164846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'Microemulsion Topical Delivery Platform'
[patent_app_type] => utility
[patent_app_number] => 14/630073
[patent_app_country] => US
[patent_app_date] => 2015-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17015
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14630073
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/630073 | Microemulsion topical delivery platform | Feb 23, 2015 | Issued |
Array
(
[id] => 11647936
[patent_doc_number] => 20170143837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'COMPOSITION FOR SKIN PENETRATION, CONTAINING CATIONIC MOLECULE TRANSPORTER AND ANIONIC BIOACTIVE MATERIAL'
[patent_app_type] => utility
[patent_app_number] => 15/317315
[patent_app_country] => US
[patent_app_date] => 2015-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6136
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317315
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/317315 | COMPOSITION FOR SKIN PENETRATION, CONTAINING CATIONIC MOLECULE TRANSPORTER AND ANIONIC BIOACTIVE MATERIAL | Feb 15, 2015 | Abandoned |
Array
(
[id] => 11262173
[patent_doc_number] => 09486454
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-08
[patent_title] => 'Hydrazaline hydrochloride pellets and method of preparation'
[patent_app_type] => utility
[patent_app_number] => 14/620405
[patent_app_country] => US
[patent_app_date] => 2015-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 18
[patent_no_of_words] => 1857
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14620405
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/620405 | Hydrazaline hydrochloride pellets and method of preparation | Feb 11, 2015 | Issued |
Array
(
[id] => 11772406
[patent_doc_number] => 09381156
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-05
[patent_title] => 'Stabilized, sprayable emulsion containing active agent particles'
[patent_app_type] => utility
[patent_app_number] => 14/619108
[patent_app_country] => US
[patent_app_date] => 2015-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 10940
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14619108
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/619108 | Stabilized, sprayable emulsion containing active agent particles | Feb 10, 2015 | Issued |
Array
(
[id] => 10013049
[patent_doc_number] => 09056052
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-06-16
[patent_title] => 'Controlled release hydrocodone formulations'
[patent_app_type] => utility
[patent_app_number] => 14/612483
[patent_app_country] => US
[patent_app_date] => 2015-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12938
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14612483
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/612483 | Controlled release hydrocodone formulations | Feb 2, 2015 | Issued |
Array
(
[id] => 10345907
[patent_doc_number] => 20150230912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'METHOD OF MANUFACTURING HYBRID SCAFFOLD AND HYBRID SCAFFOLD MANUFACTURED BY THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/590052
[patent_app_country] => US
[patent_app_date] => 2015-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7586
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14590052
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/590052 | Method of manufacturing hybrid scaffold and hybrid scaffold manufactured by the same | Jan 5, 2015 | Issued |
Array
(
[id] => 11127879
[patent_doc_number] => 20160324854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING AZD9291'
[patent_app_type] => utility
[patent_app_number] => 15/109170
[patent_app_country] => US
[patent_app_date] => 2015-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13352
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15109170
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/109170 | Pharmaceutical compositions comprising AZD9291 | Jan 1, 2015 | Issued |
Array
(
[id] => 9977094
[patent_doc_number] => 09023401
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-05-05
[patent_title] => 'Controlled release hydrocodone formulations'
[patent_app_type] => utility
[patent_app_number] => 14/581175
[patent_app_country] => US
[patent_app_date] => 2014-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12933
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14581175
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/581175 | Controlled release hydrocodone formulations | Dec 22, 2014 | Issued |
Array
(
[id] => 16891981
[patent_doc_number] => 11033507
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Method of synthesis of silica vesicles and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/106825
[patent_app_country] => US
[patent_app_date] => 2014-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 43
[patent_no_of_words] => 23254
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 216
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15106825
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/106825 | Method of synthesis of silica vesicles and use thereof | Dec 18, 2014 | Issued |
Array
(
[id] => 11191630
[patent_doc_number] => 09422433
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-23
[patent_title] => 'Ternary antifouling compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 14/575625
[patent_app_country] => US
[patent_app_date] => 2014-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 39
[patent_no_of_words] => 11629
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14575625
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/575625 | Ternary antifouling compositions and methods | Dec 17, 2014 | Issued |
Array
(
[id] => 11127798
[patent_doc_number] => 20160324772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'OPTIMIZED PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMATORY CONDITIONS OF THE ESOPHAGUS'
[patent_app_type] => utility
[patent_app_number] => 15/107735
[patent_app_country] => US
[patent_app_date] => 2014-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5756
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15107735
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/107735 | Optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagus | Dec 17, 2014 | Issued |
Array
(
[id] => 11249251
[patent_doc_number] => 09474735
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-25
[patent_title] => 'Liver function improvement and treatment of liver disease'
[patent_app_type] => utility
[patent_app_number] => 14/574036
[patent_app_country] => US
[patent_app_date] => 2014-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4783
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14574036
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/574036 | Liver function improvement and treatment of liver disease | Dec 16, 2014 | Issued |